Paclitaxel as a Salvage Chemotherapy in Patients With Gemcitabine-Refractory Pancreatic Cancer

被引：0
|
作者：
Maeda, S. [1 ]
Motoi, F. [1 ]
Kawaguchi, K. [1 ]
Onogawa, T. [1 ]
Morikawa, T. [1 ]
Okaue, A. [1 ]
Takadate, T. [1 ]
Rikiyama, T. [1 ]
Katayose, Y. [1 ]
Egawa, S. [1 ]
Unno, M. [1 ]
机构：
[1] Tohoku Univ, Div Hepatobiliary Pancreat Surg, Sendai, Miyagi 980, Japan
来源：
PANCREAS | 2009年 / 38卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1024 / 1024
页数：1
相关论文
共 50 条
  • [21] Updates on Treatment of Gemcitabine-Refractory Pancreatic Adenocarcinoma
    Makrilia, Nektaria
    Syrigos, Kostas N.
    Saif, Muhammad W.
    JOURNAL OF THE PANCREAS, 2011, 12 (04): : 351 - 354
  • [22] Preclinical combination chemotherapy of nedaplatin with gemcitabine against gemcitabine-refractory human lung cancer
    Takeda, Y
    Wada, T
    Nishitani, Y
    Matsumoto, M
    Hojo, K
    Maekawa, R
    Yoshioka, T
    CANCER LETTERS, 2002, 182 (01) : 61 - 68
  • [23] Multicenter phase Ⅱ trial of modified FOLFIRINOX in gemcitabine-refractory pancreatic cancer
    Moon Jae Chung
    Huapyong Kang
    Ho Gak Kim
    Jong Jin Hyun
    Jun Kyu Lee
    Kwang Hyuck Lee
    Myung Hwan Noh
    Dae Hwan Kang
    Sang Hyub Lee
    Seungmin Bang
    World Journal of Gastrointestinal Oncology, 2018, (12) : 505 - 515
  • [24] Second-Line Therapy for Gemcitabine-Refractory Pancreatic Cancer : Is There a Standard?
    Almhanna, Khaldoun
    Kim, Richard
    ONCOLOGY-NEW YORK, 2008, 22 (10): : 1176 - 1183
  • [25] Gemcitabine and Oxaliplatin Combination Chemotherapy for Patients with Refractory Pancreatic Cancer
    Isayama, Hiroyuki
    Nakai, Yousuke
    Yamamoto, Keisuke
    Sasaki, Takashi
    Mizuno, Suguru
    Yagioka, Hiroshi
    Yashima, Yoko
    Kawakubo, Kazumichi
    Kogure, Hirofumi
    Arizumi, Toshihiko
    Togawa, Osamu
    Ito, Yukiko
    Matsubara, Saburo
    Yamamoto, Natsuyo
    Sasahira, Naoki
    Hirano, Kenji
    Tsujino, Takeshi
    Tada, Minoru
    Omata, Masao
    Koike, Kazuhiko
    ONCOLOGY, 2011, 80 (1-2) : 97 - 101
  • [26] A phase II study of paclitaxel, oxaliplatin, leucovorin and 5-fluorouracil (POLF) in gemcitabine-refractory advanced pancreatic cancer
    Chue, Ben
    Grutsch, James
    Gupta, Digant
    Birdsall, John
    Lis, Christopher
    CANCER RESEARCH, 2009, 69
  • [27] Gemcitabine and oxaliplatine (GEMOX) in gemcitabine-refractory advanced pancreatic cancer: A phase II study.
    Van Laethem, JL
    Polus, M
    Marechal, R
    Demols, A
    Gay, F
    Marijken, M
    Hendlisz, A
    Peeters, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 343S - 343S
  • [28] Gemcitabine and cisplatin combined with regional hyperthermia as second-line treatment in patients with gemcitabine-refractory advanced pancreatic cancer
    Tschoep-Lechner, Katharina Elisabeth
    Milani, Valeria
    Berger, Frank
    Dieterle, Nelli
    Abdel-Rahman, Sultan
    Salat, Christoph
    Issels, Rolf-Dieter
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2013, 29 (01) : 8 - 16
  • [29] A case of gemcitabine-refractory pancreatic cancer responsive to second-line chemotherapy using S-1
    Morizane, Chigusa
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2007, 37 (12) : 973 - 973
  • [30] GEMCITABINE AND CISPLATIN COMBINED WITH REGIONAL HYPERTHERMIA AS SECOND-LINE TREATMENT IN PATIENTS WITH GEMCITABINE-REFRACTORY ADVANCED PANCREATIC CANCER
    Lechner, Katharina
    Berger, Frank
    Dieterle, Nelli
    Abdel-Rahman, Sultan
    Salat, Christoph
    Issels, Rolf
    ANNALS OF ONCOLOGY, 2012, 23 : 62 - 62
12345